DJIA 17,042.90 -28.32 -0.17%
NASDAQ 4,493.39 0.00 0.00%
S&P 500 1,972.29 -5.51 -0.28%
market minute promo


company name or ticker
Company Photos
(Click to zoom)

ASCO: Cancer Drug Showdown

Ariad, Pharmacyclics, and Johnson & Johnson present impressive data. Clovis battles with AstraZeneca.

ARIAD Pharmaceuticals (ARIA) Presents at Jefferies 2014 Global Healthcare Conference (Transcript)

Ignyta (RXDX) Jumps: Stock Adds 12.7% in Session - Tale of the Tape

Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Up 7.43% - Tale of the Tape

Ariad Pharmaceuticals (ARIA) Catches Eye: Stock Up 7.43% - Tale of the Tape

ARIAD Pharmaceuticals (ARIA) Is Today's Perilous Reversal Stock

'Fast Money' Recap: Apple Continues to Move Higher

Data on ImmunoGen/Sanofi's SAR3419 - Analyst Blog

Pipeline Update from Avanir - Analyst Blog

Why Conn's, MeadWestvaco, and Ariad Pharmaceuticals Jumped Today

The stock market managed to climb just enough to set new all-time records again, but these stocks left no doubt of their gains for shareholders. Find out more about what made them soar.

Up 7%: Ariad Gets Good News at Last

Ariad shares jumped today after some positive news from the ASCO conference. Watch below to find out more!